Company Search:
Advanced Search
Sponsored Links
Dimerix Ltd Company Snapshot
Dimerix Ltd operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dimerix Ltd with three other pharmaceutical manufacturers in Australasia: Acuvax Limited (2016 sales of 29,914.00 Australian Dollars [US$22,975.45 ] ), MGC Pharmaceuticals Ltd (48,230.00 Australian Dollars [US$37,043.05 ] ), and Prescient Therapeutics Ltd (10,704.00 Australian Dollars [US$8,221.21 ] ).

Sales Analysis. Dimerix Ltd reported sales of A$45,311.00 (US$34.80 thousand) for the fiscal year ending June of 2016. This represents an increase of 44.2% versus 2015, when the company's sales were A$31,423.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dimerix Ltd
  Stock Performance Chart for Dimerix Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .01
(Figures in Australian Dollars)
1 Week -7.7%   13 Weeks -14.3%  
4 Weeks -25.0%   52 Weeks -25.0%  
Dimerix Ltd Key Data:
  Ticker: DXB Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 45,311
(Year Ending Jan 2017).
Employees: 9
  Currency: Australian Dollars Market Cap: 8,979,698
  Fiscal Yr Ends: June Shares Outstanding: 1,496,616,319
  Share Type: Ordinary Closely Held Shares: 745,418,898
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.